SLE 66C162P Short Product Information

Ref.: SPI_SLE66C162P_0801.doc

This document contains preliminary information on a new product under development.

Details are subject to change without notice.

Revision History:

Current Version 08.01

Previous Releases:

Page

Subjects (changes since last revision)

Important: Further information is confidential and on request. Please contact:

Infineon Technologies AG in Munich, Germany,

Security & Chip Card ICs,

Tel +49 - (0)89 234-80000

Fax +49 - (0)89 234-81000

E-Mail: security.chipcard.ics@infineon.com

Edition 2001

Published by Infineon Technologies AG, CC Applications Group

St.-Martin-Strasse 53, D-81541 München

© Infineon Technologies AG 2001

All Rights Reserved.

Attention please!

The information herein is given to describe certain components and shall not be considered as warranted characteristics.

Terms of delivery and rights to technical change reserved.

We hereby disclaim any and all warranties, including but not limited to warranties of non-infringement, regarding circuits,

descriptions and charts stated herein.

Infineon Technologies is an approved CECC manufacturer.

Information

For further information on technology, delivery terms and conditions and prices please contact your nearest Infineon

Technologies Office in Germany or our Infineon Technologies Representatives world-wide (see address list).

Warnings

Due to technical requirements components may contain dangerous substances. For information on the types in question please

contact your nearest Infineon Technologies Office.

Infineon Technologies Components may only be used in life-support devices or systems with the express written approval of

Infineon Technologies, if a failure of such components can reasonably be expected to cause the failure of that life-support

device or system, or to affect the safety or effectiveness of that device or system. Life support devices or systems are intended

to be implanted in the human body, or to support and/or maintain and sustain and/or protect human life. If they fail, it is

reasonable to assume that the health of the user or other persons may be endangered.